A role for the p75 neurotrophin receptor in axonal degeneration and apoptosis induced by oxidative stress

Journal of Biological Chemistry

Volumn 289, Issue 31, 2014, Pages 21205-21216

  Kraemer, Bradley R ^a   Snow, John P ^a   Vollbrecht, Peter ^a   Pathak, Amrita ^a   Valentine, William M ^a   Deutch, Ariel Y ^a   Carter, Bruce D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; ENZYME INHIBITION; LIGANDS; MAMMALS; OXIDATIVE STRESS; PROTEOLYSIS;

6-HYDROXYDOPAMINE; APOPTOTIC SIGNALING; CONVERTING ENZYME; LIPID PEROXIDATION; P75 NEUROTROPHIN RECEPTOR; PATHOLOGICAL CONDITIONS; PHARMACOLOGICAL BLOCKADE; REACTIVE OXYGEN SPECIES;

NEURONS;

4 HYDROXYNONENAL; BLOCKING ANTIBODY; GAMMA SECRETASE; METALLOPROTEINASE; NEUROTROPHIN RECEPTOR P75; OXIDOPAMINE; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; NERVE GROWTH FACTOR RECEPTOR; TNFRSF16 PROTEIN, MOUSE; TNFRSF16 PROTEIN, RAT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; IN VIVO STUDY; LIPID PEROXIDATION; MOLECULAR MECHANICS; MOUSE; NERVE CELL NECROSIS; NERVE FIBER DEGENERATION; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SYMPATHETIC NERVE CELL; ANIMAL; APOPTOSIS; C57BL MOUSE; CELL CULTURE; NERVE FIBER; PERIMETRY; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; AXONS; CELLS, CULTURED; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NERVE GROWTH FACTOR; VISUAL FIELD TESTS;

EID: 84905364682     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.563403     Document Type: Article

References (87)

1. Kraemer, B. R., Yoon, S. O., and Carter, B. D. (2014) The biological functions and signaling mechanisms of the p75 neurotrophin receptor. Handb. Exp. Pharmacol. 220, 121-164
2. Jung, K. M., Tan, S., Landman, N., Petrova, K., Murray, S., Lewis, R., Kim, P. K., Kim, D. S., Ryu, S. H., Chao, M. V., and Kim, T. W. (2003) Regulated intramembrane proteolysis of the p75 neurotrophin receptor modulates its association with the TrkA receptor. J. Biol. Chem. 278, 42161-42169 (Pubitemid 37310483)
3. Kanning, K. C., Hudson, M., Amieux, P. S., Wiley, J. C., Bothwell, M., and Schecterson, L. C. (2003) Proteolytic processing of the p75 neurotrophin receptor and two homologs generates C-terminal fragments with signaling capability. J. Neurosci. 23, 5425-5436 (Pubitemid 36807816)
4. Weskamp, G., Schlöndorff, J., Lum, L., Becherer, J. D., Kim, T. W., Saftig, P., Hartmann, D., Murphy, G., and Blobel, C. P. (2004) Evidence for a critical role of the tumor necrosis factor α convertase (TACE) in ectodomain shedding of the p75 neurotrophin receptor (p75NTR). J. Biol. Chem. 279, 4241-4249
5. Kenchappa, R. S., Zampieri, N., Chao, M. V., Barker, P. A., Teng, H. K., Hempstead, B. L., and Carter, B. D. (2006) Ligand-dependent cleavage of the P75 neurotrophin receptor is necessary for NRIF nuclear translocation and apoptosis in sympathetic neurons. Neuron 50, 219-232
6. Kenchappa, R. S., Tep, C., Korade, Z., Urra, S., Bronfman, F. C., Yoon, S. O., and Carter, B. D. (2010) p75 neurotrophin receptor-mediated apoptosis in sympathetic neurons involves a biphasic activation of JNK and up-regulation of tumor necrosis factor-α-converting enzyme/ADAM17. J. Biol. Chem. 285, 20358-20368
7. Domeniconi, M., Zampieri, N., Spencer, T., Hilaire, M., Mellado, W., Chao, M. V., and Filbin, M. T. (2005) MAG induces regulated intramembrane proteolysis of the p75 neurotrophin receptor to inhibit neurite outgrowth. Neuron 46, 849-855 (Pubitemid 40805346)
8. Kommaddi, R. P., Thomas, R., Ceni, C., Daigneault, K., and Barker, P. A. (2011) Trk-dependent ADAM17 activation facilitates neurotrophin survival signaling. FASEB J. 25, 2061-2070
9. Frade, J. M., Rodríguez-Tébar, A., and Barde, Y. A. (1996) Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 383, 166-168
10. Naumann, T., Casademunt, E., Hollerbach, E., Hofmann, J., Dechant, G., Frotscher, M., and Barde, Y. A. (2002) Complete deletion of the neurotrophin receptor p75NTR leads to long-lasting increases in the number of basal forebrain cholinergic neurons. J. Neurosci. 22, 2409-2418 (Pubitemid 37465788)
11. Bamji, S. X., Majdan, M., Pozniak, C. D., Belliveau, D. J., Aloyz, R., Kohn, J., Causing, C. G., and Miller, F. D. (1998) The p75 neurotrophin receptor mediates neuronal apoptosis and is essential for naturally occurring sympathetic neuron death. J. Cell Biol. 140, 911-923 (Pubitemid 28141228)
12. Frade, J. M., and Barde, Y. A. (1999) Genetic evidence for cell death mediated by nerve growth factor and the neurotrophin receptor p75 in the developing mouse retina and spinal cord. Development 126, 683-690 (Pubitemid 29106175)
13. Park, K. J., Grosso, C. A., Aubert, I., Kaplan, D. R., and Miller, F. D. (2010) p75NTR-dependent, myelin-mediated axonal degeneration regulates neural connectivity in the adult brain. Nat. Neurosci. 13, 559-566
14. Singh, K. K., Park, K. J., Hong, E. J., Kramer, B. M., Greenberg, M. E., Kaplan, D. R., and Miller, F. D. (2008) Developmental axon pruning mediated by BDNF-p75NTR-dependent axon degeneration. Nat. Neurosci. 11, 649-658 (Pubitemid 351748111)
15. Oh, J. D., Chartisathian, K., Chase, T. N., and Butcher, L. L. (2000) Overexpression of neurotrophin receptor p75 contributes to the excitotoxin-induced cholinergic neuronal death in rat basal forebrain. Brain Res. 853, 174-185 (Pubitemid 30035217)
16. Volosin, M., Trotter, C., Cragnolini, A., Kenchappa, R. S., Light, M., Hempstead, B. L., Carter, B. D., and Friedman, W. J. (2008) Induction of proneurotrophins and activation of p75NTR-mediated apoptosis via neurotrophin receptor-interacting factor in hippocampal neurons after seizures. J. Neurosci. 28, 9870-9879
17. Harrington, A. W., Leiner, B., Blechschmitt, C., Arevalo, J. C., Lee, R., Mörl, K., Meyer, M., Hempstead, B. L., Yoon, S. O., and Giehl, K. M. (2004) Secreted proNGF is a pathophysiological death-inducing ligand after adult CNS injury. Proc. Natl. Acad. Sci. U.S.A. 101, 6226-6230 (Pubitemid 38520556)
18. Giehl, K. M., Röhrig, S., Bonatz, H., Gutjahr, M., Leiner, B., Bartke, I., Yan, Q., Reichardt, L. F., Backus, C., Welcher, A. A., Dethleffsen, K., Mestres, P., and Meyer, M. (2001) Endogenous brain-derived neurotrophic factor and neurotrophin-3 antagonistically regulate survival of axotomized corticospinal neurons in vivo. J. Neurosci. 21, 3492-3502
19. Beattie, M. S., Harrington, A. W., Lee, R., Kim, J. Y., Boyce, S. L., Longo, F. M., Bresnahan, J. C., Hempstead, B. L., and Yoon, S. O. (2002) ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury. Neuron 36, 375-386 (Pubitemid 35284727)
20. Zeng, F., Lu, J. J., Zhou, X. F., and Wang, Y. J. (2011) Roles of p75NTR in the pathogenesis of Alzheimer's disease: a novel therapeutic target. Biochem. Pharmacol. 82, 1500-1509
21. Turner, B. J., Cheah, I. K., Macfarlane, K. J., Lopes, E. C., Petratos, S., Langford, S. J., and Cheema, S. S. (2003) Antisense peptide nucleic acid-mediated knockdown of the p75 neurotrophin receptor delays motor neuron disease in mutant SOD1 transgenic mice. J. Neurochem. 87, 752-763 (Pubitemid 37310640)
22. Kokaia, Z., Andsberg, G., Martinez-Serrano, A., and Lindvall, O. (1998) Focal cerebral ischemia in rats induces expression of P75 neurotrophin receptor in resistant striatal cholinergic neurons. Neuroscience 84, 1113-1125 (Pubitemid 28157027)
23. Greferath, U., Mallard, C., Roufail, E., Rees, S. M., Barrett, G. L., and Bartlett, P. F. (2002) Expression of the p75 neurotrophin receptor by striatal cholinergic neurons following global ischemia in rats is associated with neuronal degeneration. Neurosci. Lett. 332, 57-60
24. Lorentz, C. U., Parrish, D. C., Alston, E. N., Pellegrino, M. J., Woodward, W. R., Hempstead, B. L., and Habecker, B. A. (2013) Sympathetic denervation of peri-infarct myocardium requires the p75 neurotrophin receptor. Exp. Neurol. 249, 111-119
25. Irmady, K., Jackman, K. A., Padow, V. A., Shahani, N., Martin, L. A., Cerchietti, L., Unsicker, K., Iadecola, C., and Hempstead, B. L. (2014) Mir-592 regulates the induction and cell death-promoting activity of p75NTR in neuronal ischemic injury. J. Neurosci. 34, 3419-3428
26. Shin, E. J., Jeong, J. H., Chung, Y. H., Kim, W. K., Ko, K. H., Bach, J. H., Hong, J. S., Yoneda, Y., and Kim, H. C. (2011) Role of oxidative stress in epileptic seizures. Neurochem. Int. 59, 122-137
27. Parakh, S., Spencer, D. M., Halloran, M. A., Soo, K. Y., and Atkin, J. D. (2013) Redox regulation in amyotrophic lateral sclerosis. Oxid. Med. Cell. Longev. 2013, 408681
28. Manzanero, S., Santro, T., and Arumugam, T. V. (2013) Neuronal oxidative stress in acute ischemic stroke: sources and contribution to cell injury. Neurochem. Int. 62, 712-718
29. Zuo, L., and Motherwell, M. S. (2013) The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease. Gene 532, 18-23
30. Mazzeo, A. T., Beat, A., Singh, A., and Bullock, M. R. (2009) The role of mitochondrial transition pore, and its modulation, in traumatic brain injury and delayed neurodegeneration after TBI. Exp. Neurol. 218, 363-370
31. Caldeira, G. L., Ferreira, I. L., and Rego, A. C. (2013) Impaired transcription in Alzheimer's disease: key role in mitochondrial dysfunction and oxidative stress. J. Alzheimers Dis. 34, 115-131
32. Dalleau, S., Baradat, M., Guéraud, F., and Huc, L. (2013) Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance. Cell Death Differ. 20, 1615-1630
33. Perluigi, M., Coccia, R., and Butterfield, D. A. (2012) 4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studies. Antioxid. Redox Signal. 17, 1590-1609
34. Kruman, I., Bruce-Keller, A. J., Bredesen, D., Waeg, G., and Mattson, M. P. (1997) Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 17, 5089-5100 (Pubitemid 27263822)
35. Poli, G., Schaur, R. J., Siems, W. G., and Leonarduzzi, G. (2008) 4-Hydroxynonenal: a membrane lipid oxidation product of medicinal interest. Med. Res. Rev. 28, 569-631 (Pubitemid 351842143)
36. Uchida, K., Shiraishi, M., Naito, Y., Torii, Y., Nakamura, Y., and Osawa, T. (1999) Activation of stress signaling pathways by the end product of lipid peroxidation: 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J. Biol. Chem. 274, 2234-2242
37. Kutuk, O., Adli, M., Poli, G., and Basaga, H. (2004) Resveratrol protects against 4-HNE induced oxidative stress and apoptosis in Swiss 3T3 fibroblasts. Biofactors 20, 1-10 (Pubitemid 38586205)
38. Liu, W., Kato, M., Akhand, A. A., Hayakawa, A., Suzuki, H., Miyata, T., Kurokawa, K., Hotta, Y., Ishikawa, N., and Nakashima, I. (2000) 4-Hydroxynonenal induces a cellular redox status-related activation of the caspase cascade for apoptotic cell death. J. Cell Sci. 113, 635-641 (Pubitemid 30133041)
39. Lee, J. Y., Jung, G. Y., Heo, H. J., Yun, M. R., Park, J. Y., Bae, S. S., Hong, K. W., Lee, W. S., and Kim, C. D. (2006) 4-Hydroxynonenal induces vascular smooth muscle cell apoptosis through mitochondrial generation of reactive oxygen species. Toxicol. Lett. 166, 212-221 (Pubitemid 44416551)
40. Grau, C. M., and Greene, L. A. (2012) Use of PC12 cells and rat superior cervical ganglion sympathetic neurons as models for neuroprotective assays relevant to Parkinson's disease. Methods Mol. Biol. 846, 201-211
41. Kurangi, R. F., Tilve, S. G., and Blair, I. A. (2006) Convenient and efficient syntheses of 4-hydroxy-2(E)-nonenal and 4-oxo-2(E)-nonenal. Lipids 41, 877-880 (Pubitemid 44788909)
42. Palmada, M., Kanwal, S., Rutkoski, N. J., Gustafson-Brown, C., Johnson, R. S., Wisdom, R., and Carter, B. D. (2002) C-jun is essential for sympathetic neuronal death induced by NGF withdrawal but not by p75 activation. J. Cell Biol. 158, 453-461 (Pubitemid 34851704)
43. Sasaki, Y., Vohra, B. P., Lund, F. E., and Milbrandt, J. (2009) Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide. J. Neurosci. 29, 5525-5535
44. Shin, J. E., Miller, B. R., Babetto, E., Cho, Y., Sasaki, Y., Qayum, S., Russler, E. V., Cavalli, V., Milbrandt, J., and DiAntonio, A. (2012) SCG10 is a JNK target in the axonal degeneration pathway. Proc. Natl. Acad. Sci. U.S.A. 109, E3696-3705
45. Gerdts, J., Sasaki, Y., Vohra, B., Marasa, J., and Milbrandt, J. (2011) Image-based screening identifies novel roles for IκB kinase and glycogen synthase kinase 3 in axonal degeneration. J. Biol. Chem. 286, 28011-28018
46. Deutch, A. Y., and Cameron, D. S. (1992) Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell. Neuroscience 46, 49-56
47. Bruckner, S. R., and Estus, S. (2002) JNK3 contributes to c-jun induction and apoptosis in 4-hydroxynonenal-treated sympathetic neurons. J. Neurosci. Res. 70, 665-670 (Pubitemid 35397140)
48. Chevion, M., Berenshtein, E., and Stadtman, E. R. (2000) Human studies related to protein oxidation: protein carbonyl content as a marker of damage. Free Radic. Res. 33, S99-108
49. Fischer-Hayes, L. R., Brotherton, T., and Glass, J. D. (2013) Axonal degeneration in the peripheral nervous system: implications for the pathogenesis of amyotrophic lateral sclerosis. Exp. Neurol. 246, 6-13
50. Overk, C. R., and Masliah, E. (2014) Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease. Biochem. Pharmacol. 88, 508-516
51. Babetto, E., Beirowski, B., Russler, E. V., Milbrandt, J., and DiAntonio, A. (2013) The Phr1 ubiquitin ligase promotes injury-induced axon self-destruction. Cell Rep. 3, 1422-1429
52. Causing, C. G., Gloster, A., Aloyz, R., Bamji, S. X., Chang, E., Fawcett, J., Kuchel, G., and Miller, F. D. (1997) Synaptic innervation density is regulated by neuron-derived BDNF. Neuron 18, 257-267 (Pubitemid 27111108)
53. Deppmann, C. D., Mihalas, S., Sharma, N., Lonze, B. E., Niebur, E., and Ginty, D. D. (2008) A model for neuronal competition during development. Science 320, 369-373 (Pubitemid 351555658)
54. Lee, R., Kermani, P., Teng, K. K., and Hempstead, B. L. (2001) Regulation of cell survival by secreted proneurotrophins. Science 294, 1945-1948 (Pubitemid 33101595)
55. Levi-Montalcini, R., and Hamburger, V. (1951) Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J. Exp. Zool. 116, 321-361
56. Cohen, S. (1960) Purification of a nerve-growth promoting protein from the mouse salivary gland and its neuro-cytotoxic antiserum. Proc. Natl. Acad. Sci. U.S.A. 46, 302-311
57. Bothwell, M. (2014) NGF, BDNF, NT3, and NT4. Handb. Exp. Pharmacol. 220, 3-15
58. Bové, J., and Perier, C. (2012) Neurotoxin-based models of Parkinson's disease. Neuroscience 211, 51-76
59. Tranzer, J. P., and Thoenen, H. (1968) An electron microscopic study of selective, acute degeneration of sympathetic nerve terminals after administration of 6-hydroxydopamine. Experientia 24, 155-156
60. Angeletti, P. U., and Levi-Montalcini, R. (1970) Sympathetic nerve cell destruction in newborn mammals by 6-hydroxydopamine. Proc. Natl. Acad. Sci. U.S.A. 65, 114-121
61. Saner, A., and Thoenen, H. (1971) Model experiments on the molecular mechanism of action of 6-hydroxydopamine. Mol. Pharmacol. 7, 147-154
62. Cohen, G., and Heikkila, R. E. (1974) The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. J. Biol. Chem. 249, 2447-2452
63. Alavian, K. N., Sgadò, P., Alberi, L., Subramaniam, S., and Simon, H. H. (2009) Elevated P75NTR expression causes death of engrailed-deficient midbrain dopaminergic neurons by Erk1/2 suppression. Neural Dev. 4, 11
64. Kuru, S., Sakai, M., Yoshida, M., Mimuro, M., and Hashizume, Y. (2013) Neurofibrillary tangles in the peripheral sympathetic ganglia of patients with myotonic dystrophy. Neuropathol. Appl. Neurobiol. 39, 585-588
65. Wakabayashi, K., Mori, F., Tanji, K., Orimo, S., and Takahashi, H. (2010) Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain. Acta Neuropathol. 120, 1-12
66. Del Tredici, K., Hawkes, C. H., Ghebremedhin, E., and Braak, H. (2010) Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease. Acta Neuropathol. 119, 703-713
67. Orimo, S., Uchihara, T., Nakamura, A., Mori, F., Kakita, A., Wakabayashi, K., and Takahashi, H. (2008) Axonal α-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Brain 131, 642-650 (Pubitemid 351294710)
68. Bloch, A., Probst, A., Bissig, H., Adams, H., and Tolnay, M. (2006) α-Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol. Appl. Neurobiol. 32, 284-295
69. Wang, Y. Q., Bian, G. L., Bai, Y., Cao, R., and Chen, L. W. (2008) Identification and kainic acid-induced up-regulation of low-affinity p75 neurotrophin receptor (p75NTR) in the nigral dopamine neurons of adult rats. Neurochem. Int. 53, 56-62
70. Sgadò, P., Albéri, L., Gherbassi, D., Galasso, S. L., Ramakers, G. M., Alavian, K. N., Smidt, M. P., Dyck, R. H., and Simon, H. H. (2006) Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice. Proc. Natl. Acad. Sci. U.S.A. 103, 15242-15247
71. Aronica, E., Ravizza, T., Zurolo, E., and Vezzani, A. (2012) Astrocyte immune responses in epilepsy. Glia 60, 1258-1268
72. Kaur, C., Rathnasamy, G., and Ling, E. A. (2013) Roles of activated microglia in hypoxia induced neuroinflammation in the developing brain and the retina. J. Neuroimmune Pharmacol. 8, 66-78
73. Choi, S., and Friedman, W. J. (2009) Inflammatory cytokines IL-1β and TNF-α regulate p75NTR expression in CNS neurons and astrocytes by distinct cell-type-specific signalling mechanisms. ASN Neuro 1, e00010
74. Choi, S., and Friedman, W. J. (2014) Interleukin-1β enhances neuronal vulnerability to proNGF-mediated apoptosis by increasing surface expression of p75(NTR) and sortillin. Neuroscience 257, 11-19
75. Vilar, M., Charalampopoulos, I., Kenchappa, R. S., Reversi, A., Klos-Applequist, J. M., Karaca, E., Simi, A., Spuch, C., Choi, S., Friedman, W. J., Ericson, J., Schiavo, G., Carter, B. D., and Ibáñez, C. F. (2009) Ligand-independent signaling by disulfide-crosslinked dimers of the p75 neurotrophin receptor. J. Cell Sci. 122, 3351-3357
76. Coulson, E. J., Reid, K., Baca, M., Shipham, K. A., Hulett, S. M., Kilpatrick, T. J., and Bartlett, P. F. (2000) Chopper, a new death domain of the p75 neurotrophin receptor that mediates rapid neuronal cell death. J. Biol. Chem. 275, 30537-30545
77. Rabizadeh, S., Oh, J., Zhong, L. T., Yang, J., Bitler, C. M., Butcher, L. L., and Bredesen, D. E. (1993) Induction of apoptosis by the low-affinity NGF receptor. Science 261, 345-348 (Pubitemid 23281003)
78. Roux, P. P., Bhakar, A. L., Kennedy, T. E., and Barker, P. A. (2001) The p75 neurotrophin receptor activates Akt (protein kinase B) through a phosphatidylinositol 3-kinase-dependent pathway. J. Biol. Chem. 276, 23097-23104
79. Bhakar, A. L., Howell, J. L., Paul, C. E., Salehi, A. H., Becker, E. B., Said, F., Bonni, A., and Barker, P. A. (2003) Apoptosis induced by p75NTR overexpression requires Jun kinase-dependent phosphorylation of Bad. J. Neurosci. 23, 11373-11381 (Pubitemid 37549693)
80. Sachs, B. D., Baillie, G. S., McCall, J. R., Passino, M. A., Schachtrup, C., Wallace, D. A., Dunlop, A. J., MacKenzie, K. F., Klussmann, E., Lynch, M. J., Sikorski, S. L., Nuriel, T., Tsigelny, I., Zhang, J., Houslay, M. D., Chao, M. V., and Akassoglou, K. (2007) p75 neurotrophin receptor regulates tissue fibrosis through inhibition of plasminogen activation via a PDE4/cAMP/PKA pathway. J. Cell Biol. 177, 1119-1132 (Pubitemid 46955714)
81. Zhang, Z., Oliver, P., Lancaster, J. R., Jr., Schwarzenberger, P. O., Joshi, M. S., Cork, J., and Kolls, J. K. (2001) Reactive oxygen species mediate tumor necrosis factor α-converting, enzyme-dependent ectodomain shedding induced by phorbol myristate acetate. FASEB J. 15, 303-305
82. Wang, Y., Herrera, A. H., Li, Y., Belani, K. K., and Walcheck, B. (2009) Regulation of mature ADAM17 by redox agents for L-selectin shedding. J. Immunol. 182, 2449-2457
83. Myers, T. J., Brennaman, L. H., Stevenson, M., Higashiyama, S., Russell, W. E., Lee, D. C., and Sunnarborg, S. W. (2009) Mitochondrial reactive oxygen species mediate GPCR-induced TACE/ADAM17-dependent transforming growth factor-α shedding. Mol. Biol. Cell 20, 5236-5249
84. Brill, A., Chauhan, A. K., Canault, M., Walsh, M. T., Bergmeier, W., and Wagner, D. D. (2009) Oxidative stress activates ADAM17/TACE and induces its target receptor shedding in platelets in a p38-dependent fashion. Cardiovasc. Res. 84, 137-144
85. Tyurina, Y. Y., Nylander, K. D., Mirnics, Z. K., Portugal, C., Yan, C., Zaccaro, C., Saragovi, H. U., Kagan, V. E., and Schor, N. F. (2005) The intracellular domain of p75NTR as a determinant of cellular reducing potential and response to oxidant stress. Aging Cell 4, 187-196 (Pubitemid 41602740)
86. Ceni, C., Kommaddi, R. P., Thomas, R., Vereker, E., Liu, X., McPherson, P. S., Ritter, B., and Barker, P. A. (2010) The p75NTR intracellular domain generated by neurotrophin-induced receptor cleavage potentiates Trk signaling. J. Cell Sci. 123, 2299-2307
87. Thoenen, H., and Tranzer, J. P. (1973) The pharmacology of 6-hydroxydopamine. Annu. Rev. Pharmacol. 13, 169-180